Start for free
Start for free
Elm Street Ventures logo

Elm Street Ventures

North America, Connecticut, United States, New Haven

Description

ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale

Investor Profile

Elm Street Ventures has made 28 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

  • Series A (43%)
  • Series Unknown (21%)
  • Seed (18%)
  • Series B (14%)
  • Series C (4%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Medical
  • Pharmaceutical
  • Chemical
  • Renewable Energy
  • Software
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Elm Street Ventures frequently co-invest with?

HBM Healthcare Investments
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Hatteras Venture Partners
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Canaan Partners
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Alpine Meridian
Alpine Meridian
North America, New York, United States, New York
Co-Investments: 2
Connecticut Innovations
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 12
ATDC
ATDC
North America, Georgia, United States, Atlanta
Co-Investments: 2
Advantage Capital
Advantage Capital
North America, Louisiana, United States, New Orleans
Co-Investments: 3
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 4
Cota Capital
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 2
New York Angels
New York Angels
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Elm Street Ventures?

Halda Therapeutics

New Haven, Connecticut, United States

Halda Therapeutics is a research-stage drug discovery company.

BiotechnologyMedicalTherapeutics
Series BAug 12, 2024
Amount Raised: $126,000,000
EvolveImmune Therapeutics

Branford, Connecticut, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series UnknownNov 16, 2023
Amount Raised: $37,398,371
CellFE

Alameda, California, United States

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

BiotechnologyHealth Care
Series ASep 27, 2023
Amount Raised: $22,000,000
P2 Science

Woodbridge, Connecticut, United States

P2 Science develops a bio-refining process for the conversion of biomass such as vegetable oils into high-value specialty chemicals.

BiotechnologyChemicalRenewable Energy
Series UnknownFeb 23, 2023
Allyx Therapeutics

New Haven, Connecticut, United States

Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.

BiotechnologyHealth CareLife ScienceMedical
Series AJun 1, 2021
Amount Raised: $7,581,493
Cybrexa Therapeutics

New Haven, Connecticut, United States

Cybrexa Therapeutics is a cancer therapeutics company developing a new class of small molecule DNA repair.

BiotechnologyPharmaceuticalTherapeutics
Series BMar 10, 2021
Amount Raised: $25,000,000
Artizan Biosciences

New York, New York, United States

Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.

BiopharmaBiotechnologyHealth CareLife Science
Series AMar 1, 2021
Amount Raised: $18,877,921
P2 Science

Woodbridge, Connecticut, United States

P2 Science develops a bio-refining process for the conversion of biomass such as vegetable oils into high-value specialty chemicals.

BiotechnologyChemicalRenewable Energy
Series CJan 29, 2020
Amount Raised: $12,000,000
CellFE

Alameda, California, United States

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

BiotechnologyHealth Care
SeedJan 16, 2020
Amount Raised: $4,800,000
EvolveImmune Therapeutics

Branford, Connecticut, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series AJan 8, 2020
Amount Raised: $17,549,992
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator